307996
Bringing Down the Flag: Streamlining the Growing Population of Patients on Contact Precautions for Methicillin Resistant Staphylococcus Aurues
Methods. Outpatients with a flag of past MRSA identified through the electronic medical record were invited to participate. They were screened with nasal, inguinal, and axillary cultures for MRSA, and a nasal swab for MRSA DNA by polymerase chain reaction (PCR). If all samples were negative, they returned for a second set of samples 1 week later. Contact precaution flags were removed if all results were negative.
Results. 139 patients completed the study. 72% of study participants tested completely negative and had their flags removed. The negative predictive value of a single initial nasal PCR was 92%. Patients with a more recent history of MRSA infection, or recent hospitalization were more likely to be persistent carriers.
Conclusions. The majority of patients labelled as MRSA carriers do not need to be in continued isolation. A single nasal PCR is a rapid test that reasonably predicts which patients have cleared their colonization and can have their flag removed. Excluding patients with recent MRSA or hospitalization could improve the negative predictive value even further.
Learning Areas:
EpidemiologyProtection of the public in relation to communicable diseases including prevention or control
Public health or related organizational policy, standards, or other guidelines
Learning Objectives:
Assess the prevalence of persistent MRSA carriage in patients with a past history of MRSA colonization or infection
Demonstrate a streamlined process for health systems to identify patients that no longer need to be labeled as MRSA carriers
Keyword(s): Epidemiology, Quality Improvement
Organization/institution whose products or services will be discussed:
Qualified on the content I am responsible for because: I was the principal research coordinator for the study
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.